{
    "name": "laronidase",
    "comment": "Rx",
    "other_names": [
        "Aldurazyme"
    ],
    "classes": [
        "Enzymes",
        "Metabolic"
    ],
    "source": "https://reference.medscape.com/drug/aldurazyme-laronidase-342863",
    "pregnancy": {
        "common": [
            "An MPS I Registry has been established and pregnant women with MPS I should be encouraged to enroll; for more information, visit www.registrynxt.com or call 1-800-745-4447 ext. 15500",
            "Available data from published case reports and postmarketing experience in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes"
        ],
        "specific": [
            {
                "type": "Animal studies",
                "description": [
                    "No evidence of fetal harm observed in rats when laronidase was administered during organogenesis at doses up to 6.2 times the recommended human dose"
                ]
            },
            {
                "type": "Clinical considerations",
                "description": [
                    "Pregnancy can exacerbate preexisting clinical manifestations of MPS and lead to adverse pregnancy outcomes for both mother and fetus"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Data are not available on the presence of laronidase in human milk or the effects on milk production",
            "No adverse effects have been reported in breastfed infants in a few postmarketing cases of laronidase use in lactating women"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Anaphylactoid reactions, which may be life threatening, have been observed in some patients during infusions",
                "Patients with compromised respiratory function or acute respiratory distress may be at risk of serious acute exacerbation of their respiratory compromise due to infusion reactions and require additional monitoring"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Consider registration in the MPS I Registry, www.MPSIregistry.com or 1-800-745-4447",
                "Consider delaying treatment in patients with acute febrile/respiratory illness; may increase risk of infusion related reactions; premedication with antihistamines and antipyretics recommended; decrease infusion rate temporarily; manage reactions by administering additional antipyretics and antihistamines",
                "Use caution in patients with fluid overloads or in conditions where fluid restriction is indicated; exacerbation of such conditions may occur during infusions",
                "Not indicated for CNS manifestations of the disorder",
                "Use caution in patients with sleep apnea; apnea treatment options should be readily available during infusion or with use of sedating antihistamines including supplemental oxygen and CPAP"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Rash",
            "percent": "13"
        },
        {
            "name": "Flushing",
            "percent": "11"
        },
        {
            "name": "Pyrexia",
            "percent": "11"
        },
        {
            "name": "Headache",
            "percent": "9"
        },
        {
            "name": "Abdominal pain or discomfort",
            "percent": "9"
        },
        {
            "name": "Nausea",
            "percent": "7"
        },
        {
            "name": "Diarrhea",
            "percent": "7"
        },
        {
            "name": "Feeling hot or cold",
            "percent": "7"
        },
        {
            "name": "Vomiting",
            "percent": "4"
        },
        {
            "name": "Pruritus",
            "percent": "4"
        },
        {
            "name": "Arthralgia",
            "percent": "4"
        },
        {
            "name": "Urticaria",
            "percent": "4"
        }
    ]
}